genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2019
Celgene
Drug Discovery
Celgene Licenses Aprinoia Tau PET Tracer APN-1607 to Support Patient Selection in Trials
Drug Discovery
Evotec and Celgene Ink Oncology Deal
A-Lists
Top 10 Immuno-Oncology Collaborations
Industry News
Celgene, Prothena Partner on Neurodegenerative Treatments
Cancer
Celgene to Acquire Juno for $9B, Expanding CAR-T, TCR Presence
A-Lists
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
Industry News
Celgene Weighs Fate of Crohn’s Candidate GED-0301 after Phase III Failures
Industry News
Evotec Wins $5M First Milestone Payment from Celgene in Neuro Partnership
Cancer
Celgene Ends Option to Buy Sutro, Gains Rights to I/O Candidates in Revised Collaboration
Cancer
Celgene Agrees to Pay $280M in Whistleblower Suit Settlement
1
2
3
...
13
Page 2 of 13
Scroll Up